Synjardy 12.5 mg

SYNJARDY 12.5 MG tablets combine empagliflozin and metformin for managing type 2 diabetes. This oral medication supports blood sugar control as part of a broader treatment plan.

SYNJARDY 12.5 MG tablets are used to help manage type 2 diabetes in adults. This medication works by combining empagliflozin and metformin, which work together to lower blood sugar levels. It is often prescribed alongside diet and exercise to improve glycemic control. People often ask, 'What is SYNJARDY used for?' and the answer is that it is designed to assist in the management of type 2 diabetes.

Common effects of SYNJARDY 12.5 MG tablets may include urinary tract infections, genital fungal infections, and gastrointestinal issues like diarrhea or nausea. Some users may experience low blood sugar, especially when combined with other diabetes medications. It's important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

SYNJARDY 12.5 MG tablets should be handled with care, especially for those with kidney problems, as empagliflozin can affect kidney function. It is important to stay hydrated and avoid activities that may lead to dehydration. Regular monitoring of blood sugar levels is advised. Always follow the guidance of a healthcare professional when using this medication.

SYNJARDY 12.5 MG tablets may interact with certain medications, including diuretics, insulin, and other drugs that lower blood sugar. Alcohol can also affect the effectiveness of this medication and increase the risk of low blood sugar. It is important to discuss all current medications with a healthcare provider to avoid potential interactions.